Search
forResearch 10 of 1000+
- Implementing patient safety and quality improvement in dermatology. Part 1: Patient safety science
- Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study
- Real‐World Efficacy and Safety of Tofacitinib for Patients With Alopecia Areata: A Retrospective Multi‐Center Cohort Study
- JAAD Game Changers: Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
- Safety and patient-reported outcomes in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated with CDK4/6 inhibitors in China: A cross-sectional study.
- Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
- Efficacy and Safety of Topical Flutamide 1% Gel as an Adjunctive Therapy in the Treatment of Patients With Acne Vulgaris
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus 0.1% Ointment in Patients with Localized Alopecia Areata: A Triple-Arm Randomized Clinical Study
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
Community 10 of 97
- Kintor Pharma Announces Completion of First Patient Enrollment in KX-826 Long-term Safety Phase III Trial for Treatment of AGA
- Efficacy and Safety of Oral Dutasteride 0.5 mg Combined with Oral Minoxidil 2.5 mg for Male Androgenetic Alopecia: A Retrospective Cohort Study
- Good news for stem cells hair therapies - US federal judge: using patients' stem cells does NOT fall under FDA jurisdiction
- GT20029 - Promising phase II results
- JXL082 is not PP405 and Everychem followed the wrong lead
- The story of RU58841/PSK3841
- Be patient!! It really does work
- Positive Hair Result in Patient using Tirzepatide
- Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
- Why do patients drop back to baseline/pre-treatment soon after quitting Finasteride?
Learn 10 of 21
- Hair Multiplication
- Minoxidil
- Clascoterone
- Tofacitinib
- Thymosin Beta 4
- Dutasteride
- Exosomes
- Latanoprost
- Valproic acid
- Biotin